VIDO
1,668 posts
VIDO
@VIDOInterVac
The Vaccine and Infectious Disease Organization (VIDO) is a world leader in infectious disease research and vaccine development for humans and animals
- Very excited to announce we received authorization from Health Canada to proceed with our first COVID-19 vaccine clinical trial: bit.ly/3rjjf9D
- Congratulations to Drs. Alyson Kelvin (@akelvinlab) and Angela Rasmussen (@angie_rasmussen)! They have received $1M in total funding to study mpox (formerly known as monkeypox) from @CIHR_IRSC. Click to read more about their research: vido.org/news/vido-scie… #USaskResearch
- Amazing!!! We have now sterilized over 8000 @SaskHealth N95 masks to help ensure an emergency backup supply for SK frontline healthcare workers #COVIDー19 #COVID19SK #USask
- Thanks to support from the Government of Canada, @SKGov, @cityofsaskatoon and private donors – VIDO will lead Canada’s response to emerging infectious diseases and protect Canadians. @CanadianPM @DeputyPM_Canada @PremierScottMoe @charlieclarkyxeThe Gov’t of Canada announced $59.2 million to the #USask @VIDOInterVac to support the development of vaccine candidates and the expansion of its research facilities, including a National Centre for Pandemic Research. bit.ly/32vNHC9
- Construction of our manufacturing facility will be completed by the end of 2021 – once certified we can produce multiple #vaccine types in containment level 3 #CdnBiomanufacturing #USask #Saskatoon bit.ly/3oHtylh
- Very proud of our scientific teams working on #COVID19 research and vaccine development during these challenging times.
- It is International Day of Women and Girls in Science! Here is a snapshot of some of VIDO’s amazing #WomenInScience that are at the forefront of the fight against #COVID19
- New funding from @InnovationCA and @WD_Canada will enable us to complete our pilot-scale manufacturing to accelerate Canadian #COVID19 vaccine development
00:00 - It is an exciting day for VIDO – our Phase 1 continues with the first volunteers vaccinated! bit.ly/2YJnxKc #COVID19 #vaccine #USask
- “We are working to ensure our COVID-19 vaccine advances as rapidly as possible. Proving that the vaccine is effective in ferrets is a key milestone in the development pathway.”A major milestone: A #COVID19 vaccine candidate developed by the #USask @VIDOInterVac is moving towards human clinical trials after the novel vaccine has proven highly effective in ferrets, one of the commonly used animal models for COVID-19. bit.ly/2ZzxThG
- “This is a great example of the international partnerships needed to stop the global spread of this highly contagious virus” We look forward to working with @IVIHeadquartersThe International Vaccine Institute of South Korea is collaborating with @VIDOInterVac at #USask to better understand the virus causing the #COVID19 pandemic and to develop vaccines and potential treatments. @IVIHeadquarters @drjeromekim1 bit.ly/2UMu4lk
- Congratulations to VIDO Researcher Dr. Arinjay Banerjee (@sci_questions) for being awarded the prestigious 2024 CSV Early Career Researcher Award! We are so proud of you! #CSV2024 @CanSocVirol
- Last week we received an awesome letter of appreciation from a 12-year old in Ontario. Thank you to Christian and to everyone that has sent us encouragement and are cheering on our vaccine development efforts. Your messages are very much appreciated!!
